On the cancer frontier : one man, one disease, and a medical revolution / Paul A. Marks, MD and James Sterngold.
By: Marks, Paul A [author.].
Contributor(s): Sterngold, James [author.].
New York : PublicAffairs, 2014Edition: First edition.Description: xiv, 251 pages : illustrations ; 22 cm.ISBN: 9781610392525 (hardcover).Subject(s): Marks, Paul A | Neoplasms -- history | Antineoplastic Agents -- history | Biomedical Research | Cell Transformation, Neoplastic | Medical Oncology -- history | Neoplasms -- therapyGenre/Form: Print books.Summary: "Paul Marks M.D., President Emeritus of Memorial Sloan-Kettering Cancer Hospital, attributes the elusive nature of cancers cure to its inherently anarchic processes. There can be no hope for a miracle cure when defective cells use a myriad of tools to succeed in their relentless assaults. There are many ways cancers get started, and turn healthy cell division and growth into lethal attacks. Cancer cells and their abnormal genes are inherently unstable and so, are able to fight off anything that gets in their way-often a prescribed drug. In 1950 the discovery of cancer was all but a death sentence. By 1980, 214 of every 100,000 Americans died from cancer. As late as 1986, an article in the New England Journal of Medicine revealed the less-than-optimistic outlook cancer research, publishing the condemning sentence : we are losing the war against cancer." In fact, though cancer had not been eliminated, it had begun to be identified for what it is. A highly individualistic disease, variable-a guerrilla cell rather than a marching army. Suddenly science learned how to fight the right war-at ever closer quarters. And at the forefront of the momentous chain of discoveries was Paul Marks. Chronicling the insights of researchers and doctors around the world and the momentous effects of their pains-taking advances- Marks weaves together the humbling account of how and what we learned about the mechanisms of malignant and abnormal cells that make up every one of us"--Provided by publisher.| Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|
| On Shelf | RS431.A64 M37 2014 (Browse shelf) | Available | AU0000000003280 |
Browsing Alfaisal University Shelves , Shelving location: On Shelf Close shelf browser
|
|
|
|
|
|
|
||
| RS420 .L535 2015 Top drugs : their history, pharmacology, syntheses / | RS420 .T49 2017 Textbook of drug design and discovery / | RS424 .C66 1986 Chemical stability of pharmaceuticals : a handbook for pharmacists / | RS431.A64 M37 2014 On the cancer frontier : one man, one disease, and a medical revolution / | RT24 .D68 2018 The biomedical writer : what you need to succeed in academic medicine / | RT24 .S28 2017 Anatomy of writing for publication for nurses / | RT24 .T39 2014 Writing skills in nursing and healthcare : a guide to completing successful dissertations and theses / |
Includes bibliographical references and index.
"Paul Marks M.D., President Emeritus of Memorial Sloan-Kettering Cancer Hospital, attributes the elusive nature of cancers cure to its inherently anarchic processes. There can be no hope for a miracle cure when defective cells use a myriad of tools to succeed in their relentless assaults. There are many ways cancers get started, and turn healthy cell division and growth into lethal attacks. Cancer cells and their abnormal genes are inherently unstable and so, are able to fight off anything that gets in their way-often a prescribed drug. In 1950 the discovery of cancer was all but a death sentence. By 1980, 214 of every 100,000 Americans died from cancer. As late as 1986, an article in the New England Journal of Medicine revealed the less-than-optimistic outlook cancer research, publishing the condemning sentence : we are losing the war against cancer." In fact, though cancer had not been eliminated, it had begun to be identified for what it is. A highly individualistic disease, variable-a guerrilla cell rather than a marching army. Suddenly science learned how to fight the right war-at ever closer quarters. And at the forefront of the momentous chain of discoveries was Paul Marks. Chronicling the insights of researchers and doctors around the world and the momentous effects of their pains-taking advances- Marks weaves together the humbling account of how and what we learned about the mechanisms of malignant and abnormal cells that make up every one of us"--Provided by publisher.